ETIBI

This brand name is authorized in Austria, Canada

Active ingredients

The drug ETIBI contains one active pharmaceutical ingredient (API):

1 Ethambutol UNII QE4VW5FO07 - ETHAMBUTOL HYDROCHLORIDE

Ethambutol is bacteriostatic. It is effective against Mycobacterium tuberculosi and M.bovis with an MIC of 0.5–8µg per ml. The exact mechanism of action is unknown. While it has activity against some atypical mycobacteria including M.Kansasii, activity against other micro-organisms has not yet been reported. Read about Ethambutol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ETIBI Tablet	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J04AK02	Ethambutol	J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AK Other drugs for treatment of tuberculosis
Discover more medicines within J04AK02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00247960, 00247979